Literature DB >> 34038554

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium.

Marcia M L Kho1, Marlies E J Reinders1, Carla C Baan1, Debbie van Baarle2,3, Frederike J Bemelman4, Dimitri A Diavatopoulos5, Ron T Gansevoort6, Fiona R M van der Klis3, Marion P G Koopmans7, A Lianne Messchendorp6, Renate G van der Molen8, Ester B M Remmerswaal9, Nynke Rots3, Priya Vart6,10,11, Rory D de Vries7, Luuk B Hilbrands12, Jan-Stephan F Sanders6.   

Abstract

Entities:  

Year:  2021        PMID: 34038554     DOI: 10.1093/ndt/gfab186

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Humoral Response to BNT1622 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease.

Authors:  Delphine Kervella; Pierre Braud; Claire Garandeau; Celine Phelizot; Xavier Ambrosi; Gilles Blancho; Maryvonne Hourmant; Lucile Figueres
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-03       Impact factor: 8.237

Review 2.  Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.

Authors:  Paul Moss; Francis Berenbaum; Giuseppe Curigliano; Ayelet Grupper; Thomas Berg; Shanti Pather
Journal:  Vaccine       Date:  2022-05-27       Impact factor: 4.169

3.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.